Gene · 6738
Papers1,582
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,582
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinically Relevant Cutoffs for Anti-Extractable Nuclear Antigen Line Immunoassays. | Arch Pathol Lab Med | 2025 | 40460086 | PubTator, text mining | PubMed |
| High-throughput strategies for monoclonal antibody screening: advances and challenges. | J Biol Eng | 2025 | 40340930 | PubTator, text mining | PubMed |
| A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease. | Ann Rheum Dis | 2025 | 40320334 | PubTator, text mining | PubMed |
| Role of the anti-RO/SSA antibody in patients with systemic lupus erythematosus. | Reumatol Clin (Engl Ed) | 2025 | 40316394 | PubTator, text mining | PubMed |
| Interferons and Cytokines Induce Transcriptional Activation of the Long-Interspersed Element-1 in Myeloid Cells from Autoimmune Patients. | Eur J Immunol | 2025 | 40071709 | PubTator, text mining | PubMed |
| Establishing an in-house quality control program for nine autoantibody assays using donor sera. | Clin Biochem | 2025 | 40010535 | PubTator, text mining | PubMed |
| Anti-SSA/SSB antibody double-negative Sjögren's disease patients: a comprehensive clinical study and immune profile. | Clin Rheumatol | 2025 | 39969675 | PubTator, text mining | PubMed |
| Whole transcriptome analysis of unmutated sporadic ALS patients' peripheral blood reveals phenotype-specific gene expression signature. | Neurobiol Dis | 2025 | 39904421 | PubTator, text mining | PubMed |
| Enhanced co-expression of TIGIT and PD-1 on γδ T cells correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome. | Clin Rheumatol | 2025 | 39856468 | PubTator, text mining | PubMed |
| Impact of IgG Fc Glycosylation on Disease Dynamics in Patients With Primary Sjögren Disease. | Arthritis Rheumatol | 2025 | 39344178 | PubTator, text mining | PubMed |
| Methylome-wide association study of multidimensional resilience. | Dev Psychopathol | 2025 | 39282724 | PubTator, text mining | PubMed |
| TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. | Arthritis Rheumatol | 2025 | 39279150 | PubTator, text mining | PubMed |
| The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus. | Rheumatology (Oxford) | 2025 | 39141489 | PubTator, text mining | PubMed |
| Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients. | Rheumatology (Oxford) | 2025 | 38460182 | PubTator, text mining | PubMed |
| Epigenetic Drift Is Involved in the Efficacy of HBV Vaccination. | Vaccines (Basel) | 2024 | 39771992 | PubTator, text mining | PubMed |
| A non-invasive model for diagnosis of primary Sjogren's disease based on salivary biomarkers, serum autoantibodies, and Schirmer's test. | Arthritis Res Ther | 2024 | 39695856 | PubTator, text mining | PubMed |
| Sjögren's syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody. | J Int Med Res | 2024 | 39501720 | PubTator, text mining | PubMed |
| Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren's disease. | Ann Rheum Dis | 2024 | 39472059 | PubTator, text mining | PubMed |
| The (reverse) paradox of lupus anticoagulant: A case report. | Lupus | 2024 | 39244660 | PubTator, text mining | PubMed |
| Clearing the JUNQ: the molecular machinery for sequestration, localization, and degradation of the JUNQ compartment. | Front Mol Biosci | 2024 | 39234568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6738/papers?page=4